Sara Tezza

Dendritic cells license regulatory B cells to produce IL-10 and mediate suppression of antigen-specific CD8 T cells

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?

Purinergic regulation of the immune system

Immunogenic cell death in cancer and infectious disease

The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease

Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes

Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond

Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

Ion Channels in Innate and Adaptive Immunity

DAMP-sensing receptors in sterile inflammation and inflammatory diseases

Piezo1 channels restrain regulatory T cells but are dispensable for effector CD4 ⁺ T cell responses

Chemotherapy induces enrichment of CD47 ⁺ /CD73 ⁺ /PDL1 ⁺ immune evasive triple-negative breast cancer cells

The P2X7 receptor: Shifting from a low- to a high-conductance channel — An enigmatic phenomenon?

Metabolomics for Investigating Physiological and Pathophysiological Processes

MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights

Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site

Metabolomic Profiling in Individuals with a Failing Kidney Allograft

Interleukin-10+ Regulatory B Cells Arise Within Antigen-Experienced CD40+ B Cells to Maintain Tolerance to Islet Autoantigens

Effect of the Purinergic Inhibitor Oxidized ATP in a Model of Islet Allograft Rejection